Literature DB >> 12175107

Long-term observation of avascular necrosis of the femoral head in systemic lupus erythematosus: an MRI study.

T Yoshida1, Y Kanayama, M Okamura, N Negoro, T Inoue, J Yoshikawa.   

Abstract

OBJECTIVES: To assess long-term prognosis of clinically silent, early-stage avascular necrosis of the femoral head (ANFH) in patients with systemic lupus erythematosus (SLE).
METHODS: Twenty-four hips that showed ANFH by magnetic resonance imaging (MRI) in 13 patients with SLE were studied. All hips were radiographically normal and clinically asymptomatic. The percentage volume of necrotic bone was calculated at each study by dividing the sum of the necrotic areas by the sum of the femoral head areas from all MRI slices. Hips were also classified into three categories by the relation of the necrotic area to the weight bearing portion according to the system of the Japanese Investigation Committee for avascular necrosis of the femoral head, with modifications: Type A (medial lesions): 8 hips, Type B (central lesions): 4 hips, and Type C (lateral lesions): 12 hips. Patients were followed up with MRI for 12-95 (mean 51) months.
RESULTS: Fifteen hips improved (more than 15% reduction in the volume of necrosis), 5 did not change and 4 worsened during the observation period. All hips with a volume of necrotic area less than 25% showed improvement. All but one Type A hip and one Type B hip improved, while the mean volume of necrosis did not change in Type C. The volume of the necrotic area was smaller in Type A &amp; B than in Type C hips (p < 0.001).
CONCLUSIONS: Long-term prognosis of early-stage ANFH was favorable in patients with SLE when the necrotic area was small (less than 25%).

Entities:  

Mesh:

Year:  2002        PMID: 12175107

Source DB:  PubMed          Journal:  Clin Exp Rheumatol        ISSN: 0392-856X            Impact factor:   4.473


  6 in total

Review 1.  [Pharmacotherapeutic aspects of femoral head necrosis].

Authors:  I H Tarner; R Dinser; U Müller-Ladner
Journal:  Orthopade       Date:  2007-05       Impact factor: 1.087

2.  The natural history of asymptomatic osteonecrosis of the femoral head.

Authors:  Joon Soon Kang; Kyoung Ho Moon; Dae Gyu Kwon; Byung Ki Shin; Min Su Woo
Journal:  Int Orthop       Date:  2013-01-23       Impact factor: 3.075

3.  Elevated interleukin-18 levels correlated with disease activity in systemic lupus erythematosus.

Authors:  Min Chan Park; Yong Beom Park; Soo Kon Lee
Journal:  Clin Rheumatol       Date:  2004-04-14       Impact factor: 2.980

4.  Study on the outcome of patients with aseptic femoral head necrosis treated with percutaneous multiple small-diameter drilling core decompression: a retrospective cohort study based on magnetic resonance imaging and equivalent sphere model analysis.

Authors:  Yang Tan; Hangyuan He; Zihao Wan; Jun Qin; Yinxian Wen; Zhengqi Pan; Hua Wang; Liaobin Chen
Journal:  J Orthop Surg Res       Date:  2020-07-15       Impact factor: 2.359

5.  Gujiansan Ameliorates Avascular Necrosis of the Femoral Head by Regulating Autophagy via the HIF-1α/BNIP3 Pathway.

Authors:  Jie Han; Yuan Chai; Xiao-Yun Zhang; Feng Chen; Zhi-Wei Xu; Zhe Feng; Qian Yan; Shuai-Bo Wen; Yu-Kun Wu
Journal:  Evid Based Complement Alternat Med       Date:  2021-08-31       Impact factor: 2.629

6.  Lesion size changes in osteonecrosis of the femoral head: a long-term prospective study using MRI.

Authors:  Feng-chao Zhao; Zi-rong Li; Nian-fei Zhang; Bai-liang Wang; Wei Sun; Li-ming Cheng; Zhao-hui Liu
Journal:  Int Orthop       Date:  2009-06-17       Impact factor: 3.075

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.